Last reviewed · How we verify
NCT06274268: SARC-ONCO
Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments
NA trial testing Sarcopenia diagnostic test in Sarcopenia in 700 participants. Currently enrolling.
1 May 2027
Quick facts
| Lead sponsor | Centre Hospitalier Metropole Savoie |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 700 |
| Start date | 24 June 2024 |
| Primary completion | 1 May 2027 |
| Estimated completion | 1 May 2028 |
| Sites | 1 location across France |
Drugs / interventions tested
- Sarcopenia diagnostic test
Conditions studied
- Sarcopenia — all drugs for Sarcopenia →
- Oncology — all drugs for Oncology →
- Physical Inactivity — all drugs for Physical Inactivity →
- Toxicity Due to Chemotherapy — all drugs for Toxicity Due to Chemotherapy →
Sponsor
Centre Hospitalier Metropole Savoie
Who can join
18 and older, any sex, with Sarcopenia or Oncology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn about the effect of sarcopenic status on the occurrence of treatment-related toxicity during the first course of anti-cancer treatment in several types of cancers. The main question it aims to answer is : Is sarcopenia a predictive marker for the occurrence of toxicity in the initial phase of cancer treatment? The evaluation will focus on the body composition of the participants, assessed by impedancemetry, and on their muscular performance by standardized physical tests.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06274268
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sarcopenia
Currently open trials in the same condition.
- NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
- NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
- NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting
Other Centre Hospitalier Metropole Savoie trials
Trials by the same sponsor.
- NCT07354607 — Effect of Transcutaneous Electrical Stimulation on Peripheral Blood Flow · NA · recruiting
- NCT07172984 — The Value of Standardized Respiratory Rate Monitoring Exercises During Rheumatological Injection Procedures · NA · recruiting
- NCT06951893 — Identification of Pre-surgical Phenotypic Indicators Predictive of Quality of Life Trajectories in Obese Patients Follow · NA · not yet recruiting
- NCT06921226 — Exploratory Analysis of Interpersonal and Intrapersonal Psychological Processes Implied in Risk-taking and Suicidal Beha · NA · not yet recruiting
- NCT06847152 — Spatial Memory and Temporal Lobe Epilepsy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06274268 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Metropole Savoie
- Last refreshed: 18 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06274268.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing